NPT’s first fully developed product is a rapid diagnostic for canine skin infections which identifies effective antibiotics. Regulatory approval (USDA) is not needed. Low cost-of-goods translates into high margins in companion animal diagnostics. NPT uses a lean business model. Company footprint will include a small manufacturing facility and incubator space (M2D2) in Lowell. Limit of 4 employees until sales revenues allow expansion.